The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1276
ISSUE 1276
December 17, 2007
Issue 1276
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Two Amlodipine/ARB Combinations for Hypertension
December 17, 2007 (Issue: 1276)
The FDA has approved Exforge (Novartis) and Azor (Daiichi Sankyo), the first combinations of a calcium channel blocker (CCB) with an angiotensin receptor blocker (ARB) for treatment of hypertension. Amlodipine is the CCB in both products. The ARBs...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.